148 related articles for article (PubMed ID: 12864878)
1. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community.
Hoy WE; Wang Z; Baker PR; Kelly AM
Kidney Int Suppl; 2003 Feb; (83):S66-73. PubMed ID: 12864878
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of renal and cardiovascular disease: results of a renal and cardiovascular treatment program in an Australian aboriginal community.
Hoy WE; Wang Z; Baker PR; Kelly AM
J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S178-85. PubMed ID: 12819325
[TBL] [Abstract][Full Text] [Related]
3. Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program.
Hoy WE; Baker PR; Kelly AM; Wang Z
Med J Aust; 2000 May; 172(10):473-8. PubMed ID: 10901769
[TBL] [Abstract][Full Text] [Related]
4. Stemming the tide: reducing cardiovascular disease and renal failure in Australian Aborigines.
Hoy W; Kelly A; Jacups S; McKendry K; Baker P; MacDonald S; Wang Z; Punguatji N; Kerinauia J; Tipiloura E; Tipiloura E; Harrison C
Aust N Z J Med; 1999 Jun; 29(3):480-3. PubMed ID: 10868523
[TBL] [Abstract][Full Text] [Related]
5. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure.
Hoy WE; Wang Z; VanBuynder P; Baker PR; McDonald SM; Mathews JD
Kidney Int; 2001 Jul; 60(1):249-56. PubMed ID: 11422758
[TBL] [Abstract][Full Text] [Related]
6. Albuminuria: marker or target in indigenous populations.
Hoy W; McDonald SP
Kidney Int Suppl; 2004 Nov; (92):S25-31. PubMed ID: 15485412
[TBL] [Abstract][Full Text] [Related]
7. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community.
Hoy WE; Mathews JD; McCredie DA; Pugsley DJ; Hayhurst BG; Rees M; Kile E; Walker KA; Wang Z
Kidney Int; 1998 Oct; 54(4):1296-304. PubMed ID: 9767547
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population.
Baker PR; Hoy WE; Thomas RE
Adv Chronic Kidney Dis; 2005 Jan; 12(1):22-31. PubMed ID: 15719330
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria in a remote South Australian Aboriginal community: results of a community-based screening program for renal disease.
Shephard MD; Allen GG; Barratt LJ; Barbara JA; Paizis K; McLeod G; Brown M; Vanajek A
Rural Remote Health; 2003; 3(1):156. PubMed ID: 15877493
[TBL] [Abstract][Full Text] [Related]
10. Renal function and cardiovascular risk markers in a remote Australian Aboriginal community.
McDonald SP; Maguire GP; Hoy WE
Nephrol Dial Transplant; 2003 Aug; 18(8):1555-61. PubMed ID: 12897094
[TBL] [Abstract][Full Text] [Related]
11. The natural history of renal disease in Australian Aborigines. Part 1. Changes in albuminuria and glomerular filtration rate over time.
Hoy WE; Wang Z; VanBuynder P; Baker PR; Mathews JD
Kidney Int; 2001 Jul; 60(1):243-8. PubMed ID: 11422757
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
[TBL] [Abstract][Full Text] [Related]
13. An epidemic of renal failure among Australian Aboriginals.
Spencer JL; Silva DT; Snelling P; Hoy WE
Med J Aust; 1998 Jun; 168(11):537-41. PubMed ID: 9640302
[TBL] [Abstract][Full Text] [Related]
14. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
[TBL] [Abstract][Full Text] [Related]
15. Markers for cardiovascular and renal morbidity: expectations for an intervention programme in an Australian aboriginal community.
Hoy WE; McFarlane R; Pugsley DJ; Norman R; Mathews JD
Clin Exp Pharmacol Physiol; 1996 Aug; 23(8):S33-7. PubMed ID: 8886511
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP).
Chang TI; Li S; Chen SC; Peralta CA; Shlipak MG; Fried LF; Whaley-Connell AT; McCullough PA; Kurella Tamura M;
Am J Kidney Dis; 2013 Apr; 61(4 Suppl 2):S4-11. PubMed ID: 23507268
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study.
Hughes JT; Maple-Brown LJ; Thomas M; Lawton PD; Sinha A; Cass A; Barzi F; Jones G; Jerums G; MacIsaac RJ; O'Dea K; Hoy WE
Nephrology (Carlton); 2018 Jan; 23(1):37-45. PubMed ID: 29250918
[TBL] [Abstract][Full Text] [Related]
18. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension.
Hoy WE; Hughson MD; Singh GR; Douglas-Denton R; Bertram JF
Kidney Int; 2006 Jul; 70(1):104-10. PubMed ID: 16723986
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
20. The influence of birthweight, past poststreptococcal glomerulonephritis and current body mass index on levels of albuminuria in young adults: the multideterminant model of renal disease in a remote Australian Aboriginal population with high rates of renal disease and renal failure.
Hoy WE; White AV; Tipiloura B; Singh GR; Sharma S; Bloomfield H; Swanson CE; Dowling A; McCredie DA
Nephrol Dial Transplant; 2016 Jun; 31(6):971-7. PubMed ID: 25061125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
